Triple-Negative Breast Cancer Research and Education Act of 2025
Sponsored By: Representative Rep. Morelle, Joseph D. [D-NY-25]
Introduced
Summary
Creates a coordinated federal program to expand research, public education, and clinical guidance on triple-negative breast cancer with a clear focus on minority women and health disparities. It would add a new section to the Public Health Service Act to organize those activities across federal agencies.
Show full summary
- Families and patients: More public information on TNBC incidence, prevalence, the higher risk among minority women, and the range of treatment options for symptomatic TNBC.
- Health care providers: The Health Resources and Services Administration would develop and distribute up-to-date clinical information so providers know about elevated risks and available treatments.
- Researchers and institutes: The National Institutes of Health Director would coordinate and expand TNBC research across relevant institutes and offices, including the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences, the Office of Research on Women's Health, and the National Institute on Minority Health and Health Disparities.
- Public health partnerships: The Centers for Disease Control and Prevention may share information directly or through nonprofits, universities, and state and local agencies.
- Funding window: The bill authorizes appropriations as needed for fiscal years 2026 through 2031.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
More NIH research on triple-negative breast cancer
If enacted, NIH would expand and better coordinate research on triple-negative breast cancer. The Office of Research on Women's Health would lead coordination across NIH. The work would pay special attention to risks and outcomes for minority women. Congress would authorize funding without a set dollar amount for fiscal years 2026 through 2031.
Public and provider education on triple-negative breast cancer
If enacted, HHS, through CDC, would create and share public information on triple-negative breast cancer. Topics would include how common it is, higher risk for minority women, and treatment options. HHS could partner with nonprofits, schools, agencies, and media to spread the word. HHS, through HRSA, would provide up-to-date guidance to health care providers. Congress would authorize funding without a set dollar amount for fiscal years 2026 through 2031.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Rep. Morelle, Joseph D. [D-NY-25]
NY • D
Cosponsors
Rep. Bacon, Don [R-NE-2]
NE • R
Sponsored 3/3/2025
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 3/11/2025
Rep. Cherfilus-McCormick, Sheila [D-FL-20]
FL • D
Sponsored 3/24/2025
Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4]
GA • D
Sponsored 3/26/2025
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 3/26/2025
Rep. Evans, Dwight [D-PA-3]
PA • D
Sponsored 3/31/2025
Rep. Tonko, Paul [D-NY-20]
NY • D
Sponsored 4/28/2025
Rep. Cohen, Steve [D-TN-9]
TN • D
Sponsored 6/5/2025
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 6/23/2025
Rep. Castor, Kathy [D-FL-14]
FL • D
Sponsored 7/16/2025
Rep. Thanedar, Shri [D-MI-13]
MI • D
Sponsored 11/7/2025
Rep. Mfume, Kweisi [D-MD-7]
MD • D
Sponsored 2/23/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in